2026-04-25T01:33:20Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:43422 2026-02-13T04:43:27Z

CONFIRM Study Investigators - Placebo-controlled phase 3 study of oral BG-12 or glatiramer in muliple sclerosis /unibl/author/Fox RJ /unibl/author/Miller DH /unibl/author/Philips JT /unibl/author/HUtchinson M /unibl/author/Havrdova E /unibl/author/Kita M /unibl/author/Yang M /unibl/author/Ranghupati K /unibl/author/Novas M /unibl/author/Sweetser MT /unibl/author/Viglietta V /unibl/author/Dawson K https://www.unibl.org/sr-lat/fis/zaposlen/3330-sanja-grgic 2012-10 Academic Article text 1097 1087 /unibl/sci/idNaucniRad:23799 NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 F. RJ, M. DH, P. JT, H. M, H. E, K. M, Y. M, R. K, N. M, S. MT, V. V, D. K, S. Grgić, CONFIRM Study Investigators - Placebo-controlled phase 3 study of oral BG-12 or glatiramer in muliple sclerosis, NEW ENGLAND JOURNAL OF MEDICINE, Vol. 12, No. 367, pp. 1087 - 1097, Oct, 2012 https://www.pub.unibl.org/s/cir/item/43422